Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin vs BEP in Ovarian Germ Cell Tumors
NCT02429687Phase 3Recruiting
- Start
- Apr 2015
- Primary completion
- May 2025
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, carboplatin in Malignant ovarian germ cell tumor (OGCT). Started Apr 2015; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
Malignant ovarian germ cell tumor (OGCT)
Beyond the preview
Go deeper on NCT02429687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429687.